← Leaderboards
Joan Massague
Sloan-Kettering Institute For Cancer Res
$31,163,003
Attributed
$31,787,849
Total exposure
16
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,787,849 · 16
By mechanism
P01$8,454,433 · 5
U54$6,787,469 · 5
R35$6,244,391 · 1
R37$6,205,820 · 1
R01$2,338,473 · 1
T32$1,022,845 · 1
Top collaborators
- Marc Ladanyi5 shared
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- Neal Rosen$21,048,001
- Marc Ladanyi$28,443,479
- David R Spriggs$13,987,182
- Kenneth J Marians$27,560,768
- Jason A Koutcher$20,695,436
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsNeoplasm MetastasisGenesCancer CellMediatingTumorBaseSignal TransductionResponseMalignant NeoplasmsRelapseEventBrainLungLinkPathway InteractionsOrganIn VivoMediator Of Activation ProteinLung AdenocarcinomaMetastatic Malignant Neoplasm To BrainMetastatic Neoplasm To The BoneNeoplastic CellGene Targeting
Grant awards (80)
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer$1,062,000
R35 · FY2025 · CA · contact PI
Project I: Systems analysis of tumor-stroma interactions in brain metastasis$442,500
U54 · FY2025 · CA · contact PI
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer$976,871
R35 · FY2024 · CA · contact PI
Project I: Systems analysis of tumor-stroma interactions in brain metastasis$488,632
U54 · FY2024 · CA · contact PI
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer$1,040,760
R35 · FY2023 · CA · contact PI
Project I: Systems analysis of tumor-stroma interactions in brain metastasis$495,600
U54 · FY2023 · CA · contact PI
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer$1,040,760
R35 · FY2022 · CA · contact PI
Project I: Systems analysis of tumor-stroma interactions in brain metastasis$533,949
U54 · FY2022 · CA · contact PI
Project 1: Mediators of Lung Adenocarcinoma Metastatis$257,798
P01 · FY2022 · CA · contact PI
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer$1,062,000
R35 · FY2021 · CA · contact PI
Project 1: Mediators of Lung Adenocarcinoma Metastatis$263,058
P01 · FY2021 · CA · contact PI
The TGF Beta Signaling Pathway in Development and Cancer$1,062,000
R35 · FY2020 · CA · contact PI
Residual disease: unraveling immunosurveillance and immune evasion of disseminated tumor cells$433,277
U54 · FY2020 · CA · contact PI
Project 1: Mediators of Lung Adenocarcinoma Metastatis$263,058
P01 · FY2020 · CA · contact PI
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression$464,097
R01 · FY2019 · CA · contact PI
Residual disease: unraveling immunosurveillance and immune evasion of disseminated tumor cells$404,895
U54 · FY2019 · CA · contact PI
Project 1: Mediators of Lung Adenocarcinoma Metastatis$255,542
P01 · FY2019 · CA · contact PI
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression$468,594
R01 · FY2018 · CA · contact PI
Residual disease: unraveling immunosurveillance and immune evasion of disseminated tumor cells$424,646
U54 · FY2018 · CA · contact PI
TGF&, PI3K and HER2 Pathways in Breast Cancer Metastasis$383,886
P01 · FY2018 · CA · contact PI
Project 1: Mediators of Lung Adenocarcinoma Metastatis$263,445
P01 · FY2018 · CA · contact PI
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression$468,594
R01 · FY2017 · CA · contact PI
TGF&, PI3K and HER2 Pathways in Breast Cancer Metastasis$383,371
P01 · FY2017 · CA · contact PI
Residual disease: unraveling immunosurveillance and immune evasion of disseminated tumor cells$369,638
U54 · FY2017 · CA · contact PI
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression$468,594
R01 · FY2016 · CA · contact PI
TGF&, PI3K and HER2 Pathways in Breast Cancer Metastasis$386,459
P01 · FY2016 · CA · contact PI
Residual disease: unraveling immunosurveillance and immune evasion of disseminated tumor cells$369,883
U54 · FY2016 · CA · contact PI
Mediators of Lung Adenocarcinoma Metastasis$253,248
P01 · FY2016 · CA · contact PI
TGFB-SMAD Signaling in Stem Cell Differentiation and Tumor Suppression$468,594
R01 · FY2015 · CA · contact PI
TGF&, PI3K and HER2 Pathways in Breast Cancer Metastasis$386,717
P01 · FY2015 · CA · contact PI
Mediators of Lung Adenocarcinoma Metastasis$253,248
P01 · FY2015 · CA · contact PI
Brain Metastasis Microenvironment and Mechanisms$213,028
U54 · FY2015 · CA · contact PI
Transforming Growth Factor-Beta Signal Transduction$449,103
R37 · FY2014 · CA · contact PI
TGF&, PI3K and HER2 Pathways in Breast Cancer Metastasis$384,627
P01 · FY2014 · CA · contact PI
Mediators of Lung Adenocarcinoma Metastasis$245,804
P01 · FY2014 · CA · contact PI
Brain Metastasis Microenvironment and Mechanisms$236,655
U54 · FY2014 · CA · contact PI
Transforming Growth Factor-Beta Signal Transduction$435,215
R37 · FY2013 · CA · contact PI
Brain Metastasis Microenvironment and Mechanisms$240,435
U54 · FY2013 · CA · contact PI
Mediators of Lung Adenocarcinoma Metastasis$238,055
P01 · FY2013 · CA · contact PI
Transforming Growth Factor-Beta Signal Transduction$462,994
R37 · FY2012 · CA · contact PI
Mechanisms of Metastasis and Evasion of TGF-Beta Tumor Suppression Breast Cancer$451,618
P01 · FY2012 · CA · contact PI
Mediators of Lung Adenocarcinoma Metastasis$259,338
P01 · FY2012 · CA · contact PI
Brain Metastasis Microenvironment and Mechanisms$236,782
U54 · FY2012 · CA · contact PI
Transforming Growth Factor-Beta Signal Transduction$462,995
R37 · FY2011 · CA · contact PI
Mechanisms of Metastasis and Evasion of TGF-Beta Tumor Suppression Breast Cancer$450,927
P01 · FY2011 · CA · contact PI
Brain-Specific Metastasis Genes$354,398
P01 · FY2011 · CA · contact PI
Transforming Growth Factor-Beta Signal Transduction$477,313
R37 · FY2010 · CA · contact PI
Mechanisms of Metastasis and Evasion of TGF-Beta Tumor Suppression Breast Cancer$464,871
P01 · FY2010 · CA · contact PI
Brain-Specific Metastasis Genes$365,421
P01 · FY2010 · CA · contact PI
Identify the genes and functions enabling metastatic colonization of the brain$348,033
U54 · FY2010 · CA · contact PI
Towards Personalized Cancer Medicine$15,000
R13 · FY2010 · CA · contact PI
Identify the genes and functions enabling metastatic colonization of the brain$470,799
U54 · FY2009 · CA · contact PI
Mechanisms of Metastasis and Evasion of TGF-Beta Tumor Suppression Breast Cancer$455,760
P01 · FY2009 · CA · contact PI
Transforming Growth Factor-Beta Signal Transduction$443,262
R37 · FY2009 · CA · contact PI
Brain-Specific Metastasis Genes$356,273
P01 · FY2009 · CA · contact PI
Transforming Growth Factor-Beta Signal Transduction$443,262
R37 · FY2008 · CA · contact PI
Mechanisms of Metastasis and Evasion of TGF-Beta Tumor Suppression Breast Cancer$442,948
P01 · FY2008 · CA · contact PI
Identify the genes and functions enabling metastatic colonization of the brain$349,842
U54 · FY2008 · CA · contact PI
Brain-Specific Metastasis Genes$349,731
P01 · FY2008 · CA · contact PI
Transforming Growth Factor-Beta Signal Transduction$443,262
R37 · FY2007 · CA · contact PI
Identify the genes and functions enabling metastatic colonization of the brain$358,363
U54 · FY2007 · CA · contact PI
Brain-Specific Metastasis Genes$284,832
P01 · FY2007 · CA · contact PI
Transforming Growth Factor-Beta Signal Transduction$420,832
R37 · FY2006 · CA · contact PI
Identify the genes and functions enabling metastatic colonization of the brain$370,512
U54 · FY2006 · CA · contact PI
Transforming Growth Factor-Beta Signal Transduction$420,091
R37 · FY2005 · CA
RECEPTORS FOR TRANSFORMING GROWTH FACTOR-BETA$370,035
R37 · FY2004 · CA
TRAINING PROGRAM IN MOLECULAR AND CELLULAR BIOLOGY$194,012
T32 · FY2004 · GM
RECEPTORS FOR TRANSFORMING GROWTH FACTOR-BETA$359,257
R37 · FY2003 · CA
TRAINING PROGRAM IN MOLECULAR AND CELLULAR BIOLOGY$224,361
T32 · FY2003 · GM
RECEPTORS FOR TRANSFORMING GROWTH FACTOR-BETA$348,794
R37 · FY2002 · CA
TRAINING PROGRAM IN MOLECULAR AND CELLULAR BIOLOGY$212,619
T32 · FY2002 · GM
CELL BIOLOGY$157,506
P30 · FY2002 · CA
TGF beta targets in breast cancer progression and metastasis$0
P01 · FY2002 · CA
RECEPTORS FOR TRANSFORMING GROWTH FACTOR-BETA$338,634
R37 · FY2001 · CA
TRAINING PROGRAM IN MOLECULAR AND CELLULAR BIOLOGY$200,592
T32 · FY2001 · GM
CELL BIOLOGY$157,506
P30 · FY2001 · CA
RECEPTORS FOR TRANSFORMING GROWTH FACTOR-BETA$330,771
R37 · FY2000 · CA
CELL BIOLOGY$246,900
P30 · FY2000 · CA
TRAINING PROGRAM IN MOLECULAR AND CELLULAR BIOLOGY$191,261
T32 · FY2000 · GM
CELL BIOLOGY$157,506
P30 · FY2000 · CA